StockData
Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc (IRWD) stock

IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.85+0.02 (+0.41%)

Close on Nov 16, 2026Market cap $801.41MP/E 6.3Yield –

Ironwood Pharmaceuticals ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Ironwood Pharmaceuticals's ebitda for the twelve months ending Dec 31, 2018 was -$146.77M. For fiscal 2025 it was $99.60M, up 5.6% from the year before. The highest annual figure on record is $251.74M in fiscal 2022.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$99.60M+5.6%
FY2024Dec 31, 2024$94.32M–
FY2023Dec 31, 2023-$944.23M-475.1%
FY2022Dec 31, 2022$251.74M+7.7%
FY2021Dec 31, 2021$233.76M+60.9%
FY2020Dec 31, 2020$145.24M+15.5%
FY2019Dec 31, 2019$125.72M–
FY2018Dec 31, 2018-$146.77M–
FY2017Dec 31, 2017-$8.96M–
FY2016Dec 31, 2016-$41.59M–
FY2015Dec 31, 2015-$90.46M–
FY2014Dec 31, 2014-$157.04M–
FY2013Dec 31, 2013-$240.27M–
FY2012Dec 31, 2012-$61.44M–
FY2011Dec 31, 2011-$56.14M–
FY2010Dec 31, 2010-$54.61M–
FY2009Dec 31, 2009-$56.05M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2018Dec 31, 2018$28.91M-65.8%
Q3 FY2018Sep 30, 2018-$145.19M–
Q2 FY2018Jun 30, 2018-$13.01M–
Q1 FY2018Mar 31, 2018-$34.08M–
Q4 FY2017Dec 31, 2017$84.59M–
Q3 FY2017Sep 30, 2017-$17.67M–
Q2 FY2017Jun 30, 2017-$39.08M–
Q1 FY2017Mar 31, 2017-$36.80M–
Q4 FY2016Dec 31, 2016-$3.54M–
Q3 FY2016Sep 30, 2016-$26.09M–

More Ironwood Pharmaceuticals figures

See a number that looks wrong?